{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:39:02Z","timestamp":1793968742435,"version":"4.8.0"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2013,3,26]],"date-time":"2013-03-26T00:00:00Z","timestamp":1364256000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0060431","type":"journal-article","created":{"date-parts":[[2013,3,26]],"date-time":"2013-03-26T20:51:30Z","timestamp":1364331090000},"page":"e60431","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":229,"title":["Predictors of Mortality and Differences in Clinical Features among Patients with Cryptococcosis According to Immune Status"],"prefix":"10.1371","volume":"8","author":[{"given":"Kyle D.","family":"Brizendine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Baddley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Pappas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,3,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1378\/chest.115.3.734","article-title":"Pulmonary cryptococcosis in patients without HIV infection","volume":"115","author":"JA Aberg","year":"1999","journal-title":"Chest"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1086\/322597","article-title":"Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy","volume":"33","author":"PG Pappas","year":"2001","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/00005792-200109000-00004","article-title":"The clinical epidemiology of pulmonary cryptococcosis in non-AIDS patients at a tertiary care medical center","volume":"80","author":"RA Vilchez","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1378\/chest.124.6.2395","article-title":"Pulmonary cryptococcosis after initiation of anti-tumor necrosis factor-alpha therapy","volume":"124","author":"CA Hage","year":"2003","journal-title":"Chest"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1378\/chest.129.2.333","article-title":"Pulmonary cryptococcosis: comparison of clinical and radiographic characteristics in immunocompetent and immunocompromised patients","volume":"129","author":"WC Chang","year":"2006","journal-title":"Chest"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","article-title":"Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS","volume":"23","author":"BJ Park","year":"2009","journal-title":"AIDS"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"JR Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1056\/NEJM197907193010303","article-title":"A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis","volume":"301","author":"JE Bennett","year":"1979","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJM198708063170602","article-title":"Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks","volume":"317","author":"WE Dismukes","year":"1987","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJM199201093260202","article-title":"Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis","volume":"326","author":"MS Saag","year":"1992","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM199707033370103","article-title":"Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome","volume":"337","author":"CM van der Horst","year":"1997","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1097\/01.tp.0000173774.74388.49","article-title":"Antifungal management practices and evolution of infection in organ transplant recipients with Cryptococcus neoformans infection","volume":"80","author":"N Singh","year":"2005","journal-title":"Transplantation"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1399-3062.2009.00424.x","article-title":"Central nervous system involvement in cryptococcal infection in individuals after solid organ transplantation or with AIDS","volume":"11","author":"JA Davis","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.7883\/yoken.JJID.2008.111","article-title":"Comparison of clinical features and survival between cryptococcosis in HIV-positive and HIV-negative patients","volume":"61","author":"U Jongwutiwes","year":"2008","journal-title":"Jpn J Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jinf.2010.08.004","article-title":"Outcomes of central nervous system cryptococcosis vary with host immune function: results from a multi-center, prospective study","volume":"61","author":"MH Nguyen","year":"2010","journal-title":"J Infect"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1086\/377208","article-title":"Shunt surgery for hydrocephalus complicating cryptococcal meningitis in human immunodeficiency virus\u2013negative patients","volume":"37","author":"PC Liliang","year":"2003","journal-title":"Clin Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1086\/518607","article-title":"Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole","volume":"45","author":"T Bicanic","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1086\/588792","article-title":"High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial","volume":"47","author":"T Bicanic","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e43582","DOI":"10.1371\/journal.pone.0043582","article-title":"Comparison and temporal trends of three groups with cryptococcosis: HIV-infected, solid organ transplant, and HIV-negative\/non-trnasplant","volume":"7","author":"EW Bratton","year":"2012","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jmii.2011.12.005","article-title":"Liao CH, Chi CY, Wang YJ, Tseng SW, Chou CH, et al. Different presentations and outcomes between HIV-infected and HIV-uninfected patients with cryptococcal meningitis","volume":"45","journal-title":"J Microbiol Immunol Infect"},{"key":"ref21","first-page":"220","article-title":"Cryptococcal disease in patients with or without human immunodeficiency virus: clinical presentation and monitoring of serum cryptococcal antigen titers","volume":"42","author":"TY Lin","year":"2009","journal-title":"J Microbiol Immunol Infect"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1093\/clinids\/22.Supplement_2.S154","article-title":"Comparison of the efficacy of amphotericin B and fluconazole in the treatment of cryptococcosis in HIV-negative patients: retrospective analysis of 83 cases","volume":"22","author":"F Dromer","year":"1996","journal-title":"Clin Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/qjmed\/95.8.511","article-title":"Cryptococcaemia: clinical features and prognostic factors","volume":"95","author":"SS Jean","year":"2002","journal-title":"Q J Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3201\/eid0703.017302","article-title":"Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome","volume":"7","author":"S Husain","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1086\/511438","article-title":"Cryptococcus neoformans in organ transplant recipients: impact of calcineurin inhibitor agents on mortality","volume":"195","author":"N Singh","year":"2007","journal-title":"J Infect Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1371\/journal.pmed.0040021","article-title":"Determinants of disease presentation and outcome during cryptococcosis: the CryptoA\/D study","volume":"4","author":"F Dromer","year":"2007","journal-title":"PLoS Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e2870","DOI":"10.1371\/journal.pone.0002870","article-title":"Major role for amphotericin B-flucytosine combination in severe cryptococcosis","volume":"3","author":"F Dromer","year":"2008","journal-title":"PLoS ONE"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1471-2334-10-199","article-title":"A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease","volume":"10","author":"TT Chau","year":"2010","journal-title":"BMC Infect Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1086\/647948","article-title":"Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis","volume":"49","author":"HY Sun","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1086\/649861","article-title":"Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi","volume":"50","author":"JC Nussbaum","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/13693780701851695","article-title":"Fluconazole alone or combined with flucytosine for the treatment of AIDS-associated cryptococcal meningitis","volume":"46","author":"E Milefchik","year":"2008","journal-title":"Med Mycol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0060431","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T15:15:35Z","timestamp":1688138135000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0060431"}},"subtitle":[],"editor":[{"given":"Marta","family":"Feldmesser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,3,26]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0060431","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,26]]}}}